title: Long-term follow-up of serum immunoglobulin levels in blinatumomab-treated patients with minimal residual disease-positive B-precursor acute lymphoblastic leukemia.
authors.affiliation: Amgen Research (Munich) GmbH, Munich, Germany.
authors.forename: G
authors.initials: G
authors.lastname: Zugmaier
authors.affiliation: 1] Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany [2] Comprehensive Cancer Center Mainfranken, Universitätsklinikum Würzburg, Würzburg, Germany.
authors.forename: M S
authors.initials: MS
authors.lastname: Topp
authors.affiliation: Amgen Inc., Thousand Oaks, CA, USA.
authors.forename: S
authors.initials: S
authors.lastname: Alekar
authors.affiliation: Medical Department III, University Ulm, Ulm, Germany.
authors.forename: A
authors.initials: A
authors.lastname: Viardot
authors.affiliation: Medical Department II, City Hospital and University Hospital Schleswig-Holstein Campus Kiel, Kiel, Germany.
authors.forename: H-A
authors.initials: HA
authors.lastname: Horst
authors.affiliation: Medical Department II, City Hospital and University Hospital Schleswig-Holstein Campus Kiel, Kiel, Germany.
authors.forename: S
authors.initials: S
authors.lastname: Neumann
authors.affiliation: Bone Marrow Transplantation Center, University Münster, Münster, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Stelljes
authors.affiliation: Comprehensive Cancer Center Mainfranken, Universitätsklinikum Würzburg, Würzburg, Germany.
authors.forename: R C
authors.initials: RC
authors.lastname: Bargou
authors.affiliation: Comprehensive Cancer Center Mainfranken, Universitätsklinikum Würzburg, Würzburg, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Goebeler
authors.affiliation: Metronomia GmbH, Munich, Germany.
authors.forename: D
authors.initials: D
authors.lastname: Wessiepe
authors.affiliation: Amgen Research (Munich) GmbH, Munich, Germany.
authors.forename: E
authors.initials: E
authors.lastname: Degenhard
authors.affiliation: Center of Internal Medicine, J.W. Goethe University, Frankfurt, Germany.
authors.forename: N
authors.initials: N
authors.lastname: Gökbuget
authors.affiliation: Amgen Research (Munich) GmbH, Munich, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Klinger
mesh_terms: D018033:Antibodies, Bispecific / Q000008:administration & dosage*; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007136:Immunoglobulins / Q000097:blood*; D008297:Male; D018365:Neoplasm, Residual; D015452:Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / Q000097:blood / Q000188:drug therapy
chemical_list: D018033:Antibodies, Bispecific; D000970:Antineoplastic Agents; D007136:Immunoglobulins; C510808:blinatumomab